Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenneth Allen Myszkowski Insider Profile
4 Followers
Kenneth Allen Myszkowski, CFO at Arrowhead Pharmaceuticals, holds 400.60K shares in Arrowhead Pharmaceuticals (Ticker: ARWR). Most recently, Kenneth Allen Myszkowski Sold $40,000 shares of Arrowhead Pharmaceuticals on Mar 08, 2024 for an estimated value of 1.41M.
Kenneth Allen Myszkowski Arrowhead Pharmaceuticals (ARWR)CFO
Arrowhead Pharmaceuticals (ARWR)
CFO
Ranked #1,361 out of 98,501 Corporate Insiders
Profitable Transactions
10 out of 10 Profitable Transactions
Average Return
+57.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kenneth Allen Myszkowski's holdings
Insider Roles
CFO
Roles that Kenneth Allen Myszkowski holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 27, 2020 - Feb 27, 2021
Return:+129.60%
The most profitable trade made by Kenneth Allen Myszkowski
Kenneth Allen Myszkowski's Trading History
List of latest transactions for each holding click on a transaction to see Kenneth Allen Myszkowski's performance on stock
You May Also Like
Kenneth Allen Myszkowski insider profile FAQ
What is the percentage of profitable transactions made by Kenneth Allen Myszkowski?
The percentage of profitable transactions made by Kenneth Allen Myszkowski is 100%.
What is the average return per transaction made by Kenneth Allen Myszkowski?
The average return per transaction made by Kenneth Allen Myszkowski is 57.20%.
What stocks does Kenneth Allen Myszkowski hold?
Kenneth Allen Myszkowski holds: ARWR stocks.
What was Kenneth Allen Myszkowski’s latest transaction?
Kenneth Allen Myszkowski latest transaction was an Informative Sell of $1.41M.
What was Kenneth Allen Myszkowski's most profitable transaction?
Kenneth Allen Myszkowski’s most profitable transaction was an Informative Buy of ARWR stock on February 27, 2020. The return on the trade was 129.60%.
What is Kenneth Allen Myszkowski's role in Arrowhead Pharmaceuticals?
Kenneth Allen Myszkowski's role in Arrowhead Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.